Healthcare provider profile · identity verified

Swapna Chalasani, MD

Internal Medicine · TEMPE, AZ · NPI 1407067010

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	519	172
Levothyroxine Sodium	Levothyroxine Sodium	399	125
Losartan Potassium	Losartan Potassium	379	131
Amlodipine Besylate	Amlodipine Besylate	372	122
Rosuvastatin Calcium	Rosuvastatin Calcium	352	129
Lisinopril	Lisinopril	312	101
Metformin Hcl	Metformin Hcl	197	74
Alendronate Sodium	Alendronate Sodium	189	83
Gabapentin	Gabapentin	189	65
Simvastatin	Simvastatin	187	59
Omeprazole	Omeprazole	186	70
Pravastatin Sodium	Pravastatin Sodium	167	63
Metoprolol Succinate	Metoprolol Succinate	161	55
Metformin Hcl Er	Metformin Hcl	154	51
Hydrochlorothiazide	Hydrochlorothiazide	149	54
Atenolol	Atenolol	140	45
Fluticasone Propionate	Fluticasone Propionate	140	84
Pantoprazole Sodium	Pantoprazole Sodium	118	46
Trazodone Hcl	Trazodone Hcl	109	41
Glipizide Er	Glipizide	104	37
Trulicity	Dulaglutide	103	21
Synthroid	Levothyroxine Sodium	99	30
Albuterol Sulfate Hfa	Albuterol Sulfate	98	56
Furosemide	Furosemide	98	39
Sertraline Hcl	Sertraline Hcl	94	35
Tramadol Hcl	Tramadol Hcl	94	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	90	18
Duloxetine Hcl	Duloxetine Hcl	88	32
Potassium Chloride	Potassium Chloride	82	37
Alprazolam	Alprazolam	79	23
Shingrix	Varicella-Zoster Ge/As01b/Pf	75	64
Famotidine	Famotidine	74	34
Escitalopram Oxalate	Escitalopram Oxalate	64	26
Fluoxetine Hcl	Fluoxetine Hcl	61	15
Ozempic	Semaglutide	55	15
Zolpidem Tartrate	Zolpidem Tartrate	55	12
Metoprolol Tartrate	Metoprolol Tartrate	54	21
Venlafaxine Hcl Er	Venlafaxine Hcl	54	16
Allopurinol	Allopurinol	52	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	18
Lovastatin	Lovastatin	52	16
Clonazepam	Clonazepam	51	suppressed
Glipizide	Glipizide	51	18
Montelukast Sodium	Montelukast Sodium	51	23
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	49	25
Propranolol Hcl	Propranolol Hcl	48	18
Tamsulosin Hcl	Tamsulosin Hcl	48	20
Jardiance	Empagliflozin	43	11
Hydralazine Hcl	Hydralazine Hcl	42	15
Diclofenac Sodium	Diclofenac Sodium	40	28
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	40	suppressed
Ropinirole Hcl	Ropinirole Hcl	40	suppressed
Enalapril Maleate	Enalapril Maleate	38	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	14
Carvedilol	Carvedilol	37	13
Eliquis	Apixaban	37	19
Lorazepam	Lorazepam	37	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	30
Buspirone Hcl	Buspirone Hcl	35	12
Tizanidine Hcl	Tizanidine Hcl	35	28
Azelastine Hcl	Azelastine Hcl	33	20
Ezetimibe	Ezetimibe	33	11
Meloxicam	Meloxicam	32	17
Mirtazapine	Mirtazapine	32	11
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	29	29
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	28	28
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Prednisone	Prednisone	26	20
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Valsartan	Valsartan	26	suppressed
Azithromycin	Azithromycin	24	21
Januvia	Sitagliptin Phosphate	24	suppressed
Tradjenta	Linagliptin	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Cefdinir	Cefdinir	23	19
Pregabalin	Pregabalin	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Unifine Pentips	Pen Needle, Diabetic	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	20
Farxiga	Dapagliflozin Propanediol	22	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	22	22
Celecoxib	Celecoxib	21	13
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Finasteride	Finasteride	20	suppressed
Ibandronate Sodium	Ibandronate Sodium	20	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Gemtesa	Vibegron	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Levemir Flexpen	Insulin Detemir	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Baclofen	Baclofen	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	14
Fluconazole	Fluconazole	17	14
Bupropion Hcl	Bupropion Hcl	16	suppressed
Clotrimazole	Clotrimazole	16	12
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Methylprednisolone	Methylprednisolone	16	16
Myrbetriq	Mirabegron	16	suppressed
Promethazine Hcl	Promethazine Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	15
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Sildenafil Citrate	Sildenafil Citrate	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Diazepam	Diazepam	13	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	12
Klor-Con M10	Potassium Chloride	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error